Factors Defining T Cell Mediated Immunopathology in Psoriasis. (360G-Wellcome-078173_Z_05_Z)

£1,350,984

Psoriasis is a significant and common human immunopathology. T cells are thought to play a crucial role as disease effectors, however, factors defining T cell mediated immunopathology during disease development are poorly understood. To be able to address important outstanding scientific questions related to psoriasis pathogenesis, we have developed a novel psoriasis disease model. It represents one of the first available spontaneous human inflammatory disease models. It therefore provides for the first time the basis for the investigation of critical events in early psoriasis development and initiation of T cell mediated immunopathology. We hypothesize that T cell activation and proliferation in psoriasis is dependent on factors such as the local tissue environment, cytokines and resident antigen-presenting cells. We propose to investigate initiation and maintenance of tissue pathology with the following Key Goals: 1. Define the role of local tissue for T cell mediated immunopathology 2. Define the phenotype, function and T cell receptor repertoire of lesional T cells 3. Define key cytokines driving T cell mediated immunopathology The definition of factors involved in T cell mediated immunopathology in psoriasis will broaden our understanding and will also provide new therapeutic targets for of a common human inflammatory disease.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 1350984
Applicant Surname Nestle
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2005-10-25T00:00:00+00:00
Financial Year 2005/06
Grant Programme: Title Programme Grant
Internal ID 078173/Z/05/Z
Lead Applicant Prof Frank Nestle
Partnership Value 1350984
Planned Dates: End Date 2013-05-14T00:00:00+00:00
Planned Dates: Start Date 2006-05-15T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London